Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06345066 · ClinicalTrials.gov registry record · Phase 1

A Study of LY3841136 in Overweight and Obese Participants

A Phase 1 study of Obesity and Overweight, sponsored by Eli Lilly and Company.

Completed
Registry status
Phase 1
Development phase
96
Enrollment target
3
Study locations

NCT06345066 is a Phase 1 study of Obesity and Overweight that has completed, run by Eli Lilly and Company. The registered enrollment target is 96 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06345066, a Phase 1 study of Obesity and Overweight, has completed, sponsored by Eli Lilly and Company.

COMPLETED
Registry status
Phase 1
Development phase
96 participants
Enrollment target
3
Study locations

Study Summary

The main purpose of this study is to assess the safety and tolerability of LY3841136 when administered in combination with tirzepatide in overweight and obese patients. The study will last up to approximately 42 weeks.

Conditions Studied

Obesity Overweight

Interventions

  • DRUG Placebo
  • DRUG Tirzepatide
  • DRUG LY3841136

Study Locations (3)

Florida

  • Fortrea Clinical Research Unit - Daytona Beach

Texas

  • Fortrea Clinical Research Unit - Dallas

Wisconsin

  • Fortrea Clinical Research Unit - Madison

Trial Details

FieldValue
Enrollment Target 96 participants
Start Date 2024-04-03
Est. Completion 2025-09-29
Phase Phase 1

Sponsor

Eli Lilly and Company

1,341 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06345066

The ClinicalTrials.gov registry entry for NCT06345066 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower). The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT06345066 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Texas, Wisconsin.

Frequently Asked Questions

What is clinical trial NCT06345066 about?

NCT06345066 is a clinical study titled "A Study of LY3841136 in Overweight and Obese Participants". The main purpose of this study is to assess the safety and tolerability of LY3841136 when administered in combination with tirzepatide in overweight and obese patients. The study will last up to approximately 42 weeks.

What is the current status of trial NCT06345066?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 96 participants. The study started on 2024-04-03. Estimated completion is 2025-09-29.

What conditions does trial NCT06345066 study?

This clinical trial studies the following conditions: Obesity, Overweight.

What interventions are being tested in trial NCT06345066?

The interventions under investigation include: Placebo (DRUG), Tirzepatide (DRUG), LY3841136 (DRUG).

Who is sponsoring clinical trial NCT06345066?

This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06345066 being conducted?

This trial has 3 study locations across Florida, Texas, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Obesity

All registered trials for this condition

Overweight

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.